Compass Therapeutics Inc (CMPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2001 | 06-2000 | 06-1999 | 06-1996 | 06-1994 | |
| Gross Profit | 42,470 | 40,850 | 29,840 | 6,369 | 5,862 |
| Operating Expenses | 1,880 | 1,310 | 860 | 495 | 377 |
| Operating Income | -1,880 | -1,310 | -860 | -495 | -377 |
| Pre-tax Income | -1,880 | -1,310 | -860 | -495 | -377 |
| Net Income Continuous | -1,880 | -1,310 | -860 | -495 | -377 |
| Net Income | $-1,880 | $-1,310 | $-860 | $-495 | $-377 |
| EBITDA(a) | $680 | $670 | $-60 | $-243 | $145 |